Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Mereo is a new UK-based speciality biopharmaceutical company.
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
ByHeart is a baby nutrition company with FDA-registered infant formula.
Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
Adaptilens is a developer of an accommodating intraocular lens.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Perceptive Advisors has invested in 226 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $30.3B.
Perceptive Advisors's average investment size is $134.2M across its portfolio of 226 companies.
Recent Perceptive Advisors portfolio additions include Bridge to Life Ltd., scPharmaceuticals, Marea Therapeutics, Mereo Biopharma, Pheon Therapeutics. These companies were founded in 2020 or later.